WallStSmart

Lantronix Inc (LTRX)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 121% more annual revenue ($258.90M vs $116.91M). LTRX leads profitability with a -7.9% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

LTRX

Avoid

31

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 7.7Quality: 5.5
Piotroski: 3/9Altman Z: -0.59

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LTRXUndervalued (+57.8%)

Margin of Safety

+57.8%

Fair Value

$13.64

Current Price

$6.71

$6.93 discount

UndervaluedFair: $13.64Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LTRX1 strengths · Avg: 8.0/10
PEG RatioValuation
0.918/10

Growing faster than its price suggests

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

LTRX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$263.56M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-12.1%2/10

ROE of -12.1% — below average capital efficiency

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : LTRX

The strongest argument for LTRX centers on PEG Ratio. PEG of 0.91 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : LTRX

The primary concerns for LTRX are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

LTRX profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMMUNICATION EQUIPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 31/100) and 43.0% revenue growth. LTRX offers better value entry with a 57.8% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lantronix Inc

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Lantronix, Inc. provides Software as a Service (SaaS), hardware and engineering services for Edge Computing, Internet of Things (IoT) and Remote Environment Management (REM) in the Americas, Europe, the Middle East, Africa and Asia Pacific Japan. The company is headquartered in Irvine, California.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?